Skip to main content

Table 1 Patient characteristics at the time of clinical observation

From: Significance of serum Myostatin in hemodialysis patients

 

Total population

N

37

Gender (M/F)

23/14

Age, (years)

69.6 ± 15

BMI, (kg/m2)

26.4 ± 4.2

Diabetes, n (%)

12 (32)

Time on dialysis, months (IQR)

35 (19.5–48)

Type of dialysis, n (%)

BHD, n (%)

24 (65)

HDF, n (%)

13 (35)

Serum potassium (mEq/L)

4.6 ± 0.7

Serum albumin (g/L)

32 ± 0.4

Prealbumin (g/L)

0.3 ± 0.08

Total cholesterol (mmol/L)

3.6 ± 0.9

Triglycerides (mmol/L)

1.8 ± 0.8

Phosphate (mmol/L)

1.6 ± 0.5

McAuley index

5.6 ± 2

CRP (mg/dl), IQR

0.76 (0.25–1.2)

Transferrin (g/L)

1.7 ± 0.3

spKT/V

1.66 ± 0.3

  1. All values were determined in predialysis
  2. Abbreviations: Body mass index (BMI), Bicarbonate-hemodialysis (BHD); Hemodiafiltration (HDF), C-reactive protein (CRP), standard pool KT/V (spKT/V)